Sector Gamma As Bristol Myers Squibb CO Transaction History

Sector Gamma As

$339 Million
Q1 2024

A detailed history of Sector Gamma As transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sector Gamma As holds 498,536 shares of BMY stock, worth $20.7 Million. This represents 7.97% of its overall portfolio holdings.

Number of Shares

498,536

Previous 374,687 33.05%

Holding current value

$20.7 Million

Previous $19.2 Million 40.62%

% of portfolio

7.97%

Previous 4.89%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $5.94 Million - $6.74 Million	123,849 Added 33.05%	498,536 $27 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $14.4 Million - $17.2 Million	-297,093 Reduced 44.22%	374,687 $19.2 Million
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $9.51 Million - $10.6 Million	164,204 Added 32.35%	671,780 $39 Million
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $3.7 Million - $4.1 Million	58,005 Added 12.9%	507,576 $32.5 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $4.72 Million - $5.36 Million	71,902 Added 19.04%	449,571 $31.2 Million

Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $1.65 Million - $1.95 Million	24,042 Added 6.8%	377,669 $27.2 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $5,451 - $3.22 Million	41,931 Added 13.45%	353,627 $25.1 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $1.59 Million - $1.75 Million	-21,862 Reduced 6.55%	311,696 $24 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $924,228 - $1.11 Million	-15,033 Reduced 4.31%	333,558 $24.4 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $5.17 Million - $6.03 Million	-96,419 Reduced 21.67%	348,591 $21.7 Million
Q3 2021 Oct 29, 2021	SELL	$59.17 - $69.31 $4.64 Million - $5.44 Million	-78,483 Reduced 14.99%	445,010 $26.3 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $9.44 Million - $10.3 Million	152,431 Added 41.08%	523,493 $35 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $576,725 - $648,646	9,719 Added 2.69%	371,062 $23.4 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $10.4 Million - $11.8 Million	-179,851 Reduced 33.23%	361,343 $22.4 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $5.93 Million - $6.58 Million	-103,339 Reduced 16.03%	541,194 $32.6 Million
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $1.8 Million - $2.11 Million	-32,900 Reduced 4.86%	644,533 $37.9 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $13.4 Million - $19.4 Million	-288,000 Reduced 29.83%	677,433 $37.8 Million
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $20.7 Million - $27 Million	-421,289 Reduced 30.38%	965,433 $62 Million
Q3 2019 Nov 05, 2019	BUY	$42.77 - $50.71 $1.5 Million - $1.77 Million	35,000 Added 2.59%	1,386,722 $70.3 Million
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $301,095 - $332,946	-6,748 Reduced 0.5%	1,351,722 $61.3 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $10.4 Million - $12.4 Million	230,000 Added 20.38%	1,358,470 $64.8 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $19.9 Million - $25.8 Million	407,590 Added 56.54%	1,128,470 $58.7 Million
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $17.1 Million - $19.2 Million	309,180 Added 75.1%	720,880 $44.8 Million
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $27.1 Million - $30.5 Million	-490,526 Reduced 54.37%	411,700 $25.6 Million
Q2 2018 Aug 02, 2018	BUY	$50.53 - $62.98 $27.3 Million - $34 Million	540,220 Added 149.23%	902,226 $49.9 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $1.38 Million - $1.59 Million	-23,000 Reduced 5.97%	362,006 $22.9 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $4.47 Million - $4.88 Million	-74,600 Reduced 16.23%	385,006 $23.6 Million
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $23.7 Million - $27.4 Million	-429,784 Reduced 48.32%	459,606 $29.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	889,390	889,390 $49.6 Million

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account